These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34413681)

  • 1. Analysis of Factors Related to Lymph Node Metastasis in Early-Stage Type 1 Endometrial Cancer: Verifying the Clinical Value of Positive Threshold of the Immunohistochemical Parameter Ki67.
    Jiang P; Yuan R
    Cancer Manag Res; 2021; 13():6319-6328. PubMed ID: 34413681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining Clinicopathological Parameters and Molecular Indicators to Predict Lymph Node Metastasis in Endometrioid Type Endometrial Adenocarcinoma.
    Jiang P; Huang Y; Tu Y; Li N; Kong W; Di F; Jiang S; Zhang J; Yi Q; Yuan R
    Front Oncol; 2021; 11():682925. PubMed ID: 34422634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Immune-Inflammatory Index as a Predictor of Lymph Node Metastasis in Endometrial Cancer.
    Lei H; Xu S; Mao X; Chen X; Chen Y; Sun X; Sun P
    J Inflamm Res; 2021; 14():7131-7142. PubMed ID: 34992410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models.
    Yang B; Shan B; Xue X; Wang H; Shan W; Ning C; Zhou Q; Chen X; Luo X
    PLoS One; 2016; 11(5):e0155145. PubMed ID: 27163153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A nomogram for predicting lymph node metastasis in early gastric cancer].
    Cui H; Cao B; Deng H; Liu GB; Liang WQ; Xie TY; Ye L; Zhang QP; Wang N; Liu FD; Wei B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jan; 25(1):40-47. PubMed ID: 35067033
    [No Abstract]   [Full Text] [Related]  

  • 6. Comprehensive Assessment of ERĪ±, PR, Ki67, P53 to Predict the Risk of Lymph Node Metastasis in Low-Risk Endometrial Cancer.
    Huang Y; Jiang P; Kong W; Tu Y; Li N; Wang J; Zhou Q; Yuan R
    J Invest Surg; 2023 Dec; 36(1):2152508. PubMed ID: 36521837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive model for the preoperative assessment and prognostic modeling of lymph node metastasis in endometrial cancer.
    Asami Y; Hiranuma K; Takayanagi D; Matsuda M; Shimada Y; Kato MK; Kuno I; Murakami N; Komatsu M; Hamamoto R; Kohno T; Sekizawa A; Matsumoto K; Kato T; Yoshida H; Shiraishi K
    Sci Rep; 2022 Nov; 12(1):19004. PubMed ID: 36347927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of indicator of CA125 combined with D-dimer (ICD) for lymph node metastasis in patients with ovarian cancer: A two center cohort study.
    Zhang L; Guan Z; Yin Y; Ou C; Qian H; Tang M; Shen A
    J Cancer; 2022; 13(8):2447-2456. PubMed ID: 35711840
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitative Measurement of Progesterone Receptor Immunohistochemical Expression to Predict Lymph Node Metastasis in Endometrial Cancer.
    Hsiao YY; Fu HC; Wu CH; Lan J; Ou YC; Tsai CC; Lin H
    Diagnostics (Basel); 2022 Mar; 12(4):. PubMed ID: 35453837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment carcinoembryonic antigen combined with cancer antigen-125 for predicting lymph node metastasis in endometrial carcinoma: a retrospective cohort study.
    Huang SY; Fu HC; Wu CH; Wang SC; Ou YC; Tsai CC; Chen YY; Huang SW; Wang YW; Lin H
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11807-11813. PubMed ID: 37405474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and evaluation of a risk-scoring system for lymph node metastasis in early-stage endometrial carcinoma: Achieving preoperative risk stratification.
    Zhang Y; Zhao W; Chen Z; Zhao X; Ren P; Zhu M
    J Obstet Gynaecol Res; 2020 Nov; 46(11):2305-2313. PubMed ID: 32844525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical marker-based modeling framework to preoperatively predict lymph node and vascular space involvement in endometrial cancer patients.
    Miller HA; Tran A; LyBarger KS; Frieboes HB
    Eur J Surg Oncol; 2024 Jan; 50(1):107309. PubMed ID: 38056021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of S100A9 for lymph node metastasis in cervical cancer.
    Jiang Y; Wang Q; Xu Q; Zhang S; Cao L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 45(6):701-708. PubMed ID: 32879128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor size measured by multidetector CT in resectable colon cancer: correlation with regional lymph node metastasis and N stage.
    Mou A; Li H; Chen XL; Fan YH; Pu H
    World J Surg Oncol; 2021 Jun; 19(1):179. PubMed ID: 34134714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fully Automated Identification of Lymph Node Metastases and Lymphovascular Invasion in Endometrial Cancer From Multi-Parametric MRI by Deep Learning.
    Wang Y; Liu W; Lu Y; Ling R; Wang W; Li S; Zhang F; Ning Y; Chen X; Yang G; Zhang H
    J Magn Reson Imaging; 2024 Mar; ():. PubMed ID: 38471960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen-to-Lymphocyte Ratio Was an Independent Predictor of Lymph Node Metastasis in Patients with Clinically Node-Negative Advanced-Stage Gastric Cancer.
    Hu P; Wang W; He C
    Int J Gen Med; 2023; 16():1345-1354. PubMed ID: 37089136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Ki67 in Patients with Stage 1-2 Endometrial Cancer: Validation of the Cut-off Value of Ki67 as a Predictive Factor.
    Jiang P; Jia M; Hu J; Huang Z; Deng Y; Lai L; Ding S; Hu Z
    Onco Targets Ther; 2020; 13():10841-10850. PubMed ID: 33149602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Size at Magnetic Resonance Imaging Association With Lymph Node Metastasis and Lymphovascular Space Invasion in Resectable Cervical Cancer: A Multicenter Evaluation of Surgical Specimens.
    Chen XL; Chen GW; Xu GH; Ren J; Li ZL; Pu H; Li H
    Int J Gynecol Cancer; 2018 Oct; 28(8):1545-1552. PubMed ID: 30044321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a machine learning model to predict the risk of lymph node metastasis in renal carcinoma.
    Feng X; Hong T; Liu W; Xu C; Li W; Yang B; Song Y; Li T; Li W; Zhou H; Yin C
    Front Endocrinol (Lausanne); 2022; 13():1054358. PubMed ID: 36465636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot Study to Establish a Novel Five-Gene Biomarker Panel for Predicting Lymph Node Metastasis in Patients With Early Stage Endometrial Cancer.
    Huang CY; Liao KW; Chou CH; Shrestha S; Yang CD; Chiew MY; Huang HT; Hong HC; Huang SH; Chang TH; Huang HD
    Front Oncol; 2019; 9():1508. PubMed ID: 32039004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.